- Home
- /
- Haitong India
Business Overview
Haitong Securities India Private Limited operates in the Indian market and is a wholly-owned subsidiary of Haitong International Securities Group Limited.
It holds a Category I merchant banking license, research analyst license and stockbroker license issued by the Securities and Exchange Board of India (SEBI). It is also a trading member of the National Stock Exchange of India Limited (NSE) and the BSE Limited. The company is committed to providing a diversified range of financial products and services to both local and international clients in India.
Current Businesses
Haitong India specializes in cross border M&A advisory across multiple sectors; leveraging its global presence across Asia, the Americas & Europe.
Haitong India offers its ECM expertise in managing IPO’s and Offer for Sale (OFS) for Indian corporates. Haitong India’s key advantage is its sectorial knowledge and local distribution presence complemented by Haitong International Securities Group’s global distribution presence in geographies relevant to Indian Equities.
* For offer documents relating to transactions in India:
Joyalukkas India Limited – DRHP
Latent View Analytics Limited – Prospectus
Latent View Analytics Limited – RHP
Latent View Analytics Limited – DRHP
Reliance General Insurance Company Limited - DRHP
Srei Equipment Finance Limited – Corrigendum to DRHP
Srei Equipment Finance Limited - DRHP
HDFC Standard Life Insurance Company Limited - Prospectus
HDFC Standard Life Insurance Company Limited - RHP
HDFC Standard Life Insurance Company Limited – Corrigendum to DRHP
HDFC Standard Life Insurance Company Limited – Rectified DRHP
HDFC Standard Life Insurance Company Limited – DRHP
Central Depository Services (India) Limited – DRHP
Central Depository Services (India) Limited – RHP.
* For track record of public issues, Click here.
* For Investor Charters, Click here.
* Please click here for Terms and Conditions of Research Services.
* For Data on Investors’ Complaints, Click here.
* For Account Opening Forms, Click here.
* For Research Compliance Audit Reports, Click here.
Haitong Securities India Private Limited (Haitong India) may engage into providing the Advisory Services to the Corporates which are not regulated by Securities and Exchange Board of India (SEBI) or any other Financial Sector Regulators (FSR), hereinafter referred as "Non-Regulated Activities". This is further disclosed that no SEBI Investor Protection Mechanism will be available for any grievances or disputes arising out of or pertaining to any Non Regulated Activities.
Haitong India’s Research complements Haitong International Securities Group’s pan Asian Research capabilities. Haitong India’s Research focuses on midcaps that have the potential for high growth. Haitong India and Haitong International Securities Group have a Sales footprint across India, Hong Kong, Singapore, Japan, Korea, UK, Europe and USA.
Haitong International Securities Group Limited is one of the largest brokers in Hong Kong. The parent company, Guotai Haitong Securities Co., Ltd. (Stock Code:2611.HK), is based in Shanghai and is one of China’s largest brokers.
Please see our business area for further details including information relating to Haitong International Securities Group Limited’s full range of business activities in other jurisdictions.
Contact Us
Haitong Securities India Private Limited
1203A, Floor 12A, Tower 2A, One World Center, Elphinstone Road, Mumbai 400 013, India
CIN U74140MH2011FTC224070
- Tel: (91) 22 43156800
- Email: [email protected]
?
For redressal of their grievances against Haitong Securities India Private Limited, the Investors can reach out to its Compliance Officer - Prasanna Chandwaskar at Tel: (91) 22 43156803 and email him at [email protected]
?
Registration Details
Haitong Securities India Private Limited is registered with SEBI as a Category I Merchant Banker with Registration No. INM000012045, Stock Broker with Registration No. INZ000026435 and Research Analyst with Registration No. INH000002590.
Investments in securities are subject to market risk; please read the SEBI prescribed Combined Risk Disclosure Document prior to investing.
?